Savara Ownership | Who Owns Savara?
Savara Ownership Summary
Savara is owned by 13.81% institutional investors, 4.67% insiders, and 81.52% retail investors. Nea management company is the largest institutional shareholder, holding 11.31% of SVRA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.95% of its assets in Savara shares.
SVRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Savara | 13.81% | 4.67% | 81.52% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 24.47M | 11.31% | $87.36M |
| Bain capital life sciences investors | 17.60M | 8.13% | $62.83M |
| Vr adviser | 12.68M | 5.86% | $45.27M |
| Tcg crossover management | 12.36M | 5.71% | $44.13M |
| Frazier life sciences management | 11.46M | 5.30% | $40.92M |
| Blackrock | 8.03M | 4.40% | $32.36M |
| Nantahala capital management | 8.78M | 4.05% | $31.33M |
| Blackrock funding, inc. /de | 8.45M | 3.90% | $30.16M |
| Vanguard group | 8.31M | 3.84% | $29.68M |
| Deerfield management company, l.p. (series c) | 7.96M | 3.68% | $28.43M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rosalind advisors | 4.00M | 4.88% | $14.28M |
| Nea management company | 24.47M | 4.79% | $87.36M |
| Superstring capital management lp | 1.31M | 4.60% | $4.67M |
| Bain capital life sciences investors | 17.60M | 4.17% | $62.83M |
| Vr adviser | 12.68M | 2.55% | $45.27M |
| Tcg crossover management | 12.36M | 2.17% | $44.13M |
| Ghost tree capital | 1.05M | 1.33% | $4.24M |
| Frazier life sciences management | 11.46M | 1.23% | $40.92M |
| Nantahala capital management | 8.78M | 1.09% | $31.33M |
| Sphera funds management | 1.35M | 1.02% | $4.82M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vr adviser | 12.68M | 2.55% | 3.80M |
| Morgan stanley | 1.92M | 0.00% | 1.54M |
| Rosalind advisors | 4.00M | 4.88% | 1.35M |
| Axa investment managers | 1.05M | 0.01% | 1.05M |
| Affinity asset advisors | 1.50M | 0.47% | 1.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 4.01M | 0.65% | -7.00M |
| Jennison associates | - | - | -6.73M |
| Farallon capital management | 2.50M | 0.04% | -4.33M |
| Adage capital partners gp | - | - | -2.12M |
| Vivo capital | - | - | -2.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Axa investment managers | 1.05M | 0.01% | 1.05M | $3.76M |
| Jane street group | 605.57K | 0.00% | 605.57K | $2.16B |
| Swedbank ab | 550.00K | 0.00% | 550.00K | $1.96M |
| Renaissance | 260.10K | 0.00% | 260.10K | $928.56K |
| Graham capital management | 53.40K | 0.00% | 53.40K | $190.63K |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -3.00 |
| True wealth design | -15.00 |
| Nelson, van denburg & campbell wealth management group | -16.00 |
| Eversource wealth advisors | -20.00 |
| Natixis | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 41 | -64.66% | 29,898,714 | -82.02% | 13 | 0.23% | 14 | -75.00% | 19 | -45.71% |
| Jun 30, 2025 | 122 | -10.95% | 167,584,407 | 1.51% | 77 | 1.33% | 60 | -13.04% | 35 | -10.26% |
| Mar 31, 2025 | 12 | -91.18% | 67,904,042 | -58.30% | 34 | 0.58% | 10 | -87.50% | 1 | -96.88% |
| Dec 31, 2024 | 39 | -69.53% | 26,754,956 | -83.33% | 12 | 0.22% | 21 | -71.62% | 8 | -69.23% |
| Sep 30, 2024 | 128 | -11.72% | 160,502,555 | 8.32% | 75 | 1.15% | 74 | -15.91% | 26 | -10.34% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.10M | 2.95% | -113.17K |
| Vanguard US Total Market Shares ETF | 4.93M | 2.86% | - |
| Jennison Health Sciences Equity | 3.78M | 2.29% | 463.66K |
| PGIM Jennison Health Sciences Z | 3.78M | 2.21% | - |
| iShares Russell 2000 ETF | 3.03M | 1.75% | - |
| SPDR® S&P Biotech ETF | 1.56M | 0.91% | -9.50K |
| Fidelity Small Cap Index | 1.27M | 0.73% | 37.61K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.26M | 0.73% | -574.05K |
| iShares Russell 2000 Growth ETF | 1.14M | 0.66% | - |
| UTM IM GBP AXA Framlington Biotech | 1.01M | 0.58% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 20, 2025 | Hawkins Richard J | - | Buy | $98.57K |
| May 29, 2025 | McCracken Joseph S | - | Buy | $20.82K |
| Mar 31, 2025 | RAMSAY DAVID A | - | Buy | $416.25K |
| Dec 16, 2024 | Lowrance David L | Chief Financial Officer | Sell | $83.28K |
| Dec 16, 2024 | Pauls Matthew | CHIEF EXECUTIVE OFFICER | Sell | $180.83K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q2 | 2 | - |
| 2025 Q1 | 1 | - |
| 2024 Q4 | 2 | 3 |
| 2024 Q3 | - | - |
SVRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools